
Sign up to save your podcasts
Or


A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.
By Rahul Banerjee, MD4.8
2727 ratings
A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.

140 Listeners

324 Listeners

498 Listeners

76 Listeners

120 Listeners

28 Listeners

1,142 Listeners

187 Listeners

22 Listeners

369 Listeners

52 Listeners

138 Listeners

48 Listeners

193 Listeners

29 Listeners